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Abstract—The transcription factor NF-κB is a biological com-
ponent that is central to the regulation of genes involved in the
innate immune system. Dysregulation of the pathway is known to
be involved in a large number of inflammatory diseases. Although
considerable research has been performed since its discovery
in 1986, we are still not in a position to control the signalling
pathway, and thus limit the effects of NF-κB within promotion of
inflammatory diseases. We have developed an agent-based model
of the IL-1 stimulated NF-κB signalling pathway, which has
been calibrated to wet-lab data at the single-cell level. Through
rigorous software engineering, we believe our model provides an
abstracted view of the underlying real-world system, and can be
used in a predictive capacity through in silico experimentation. In
this study, we have focused on the dynamics of the IKK complex
and its activation of NF-κB. Our agent-based model suggests that
the pathway is sensitive to: variations in the binding probability
of IKK to the inhibited NF-κB-IκBα complex; and variations in
the temporal rebinding delay of IKK.
I. INTRODUCTION
Nuclear factor-kappa B (NF-κB) is a collective name for
a family of inducible dimeric transcription factors, which
in conjunction with its signalling pathway connects various
extracellular stimuli to the induction of gene expression. NF-
κB plays a critical role in inflammation, immunity, cell prolif-
eration, cell differentiation, and cell survival [1]. The choice
between life and death of individual cells during infection of a
host, is one of the key events in the immune response [2]. The
transcription factor NF-κB is a major player in the regulation
of such life and death decisions, and thus is central to control
of transcriptional regulation of a large number of genes that
control fundamental biological events [3].
Activation of the NF-κB transcription factor and signalling
pathway is tightly regulated and involves phosphorylation of
several members of the NF-κB and Inhibitor of kappa B (IκB)
protein families [4]. NF-κB is normally sequestered in the
cytosol of non-stimulated cells, and consequently must be
translocated into the nucleus to function as a transcriptional
activator of target genes. NF-κB activation is induced by
a wide variety of different extracellular stimuli, including
proinflammatory cytokines (such as Tumour Necrosis Factor
alpha (TNFα) and interleukin-1 (IL-1)), bacteria, viruses,
and physical and chemical stresses [5]. NF-κB activation is
thought to be controlled by two distinct pathways, which have
been termed the canonical and non-canonical pathways [6],
[7]. The two pathways are induced by different extracellular
stimuli, controlled by different intracellular kinases, operate
on different NF-κB complexes, and activate the transcription
of specific target genes [8].
NF-κB regulation is believed to be essential for the proper
function of both the innate and adaptive immune systems.
Under physiological conditions for normal (non-malignant)
cells, NF-κB activation occurs transiently upon receiving a
stimulus, due to the negative feedback regulation. Due to its
central role in gene regulation, any changes in control of its
activation can have fundamental impact on normal physiolog-
ical functions. In addition, impairment of NF-κB control is
intimately associted with disease including a variety of cancers
[9], neurodegenerative diseases [10], cardiovascular diseases
[8], and arthritis [11]. This results in potential autoimmune
responses, in particular within the central nervous system, and
resultant onset of demyelinating diseases such as Multiple
Sclerosis (MS) in humans, and the analogous Experimental
Autoimmune Encephalomyelitis in animals [2].
Understanding the mechanisms that control NF-κB activa-
tion/cellular signalling is important for exploiting therapeutic
approaches to treat human disorders due to its dysregulation.
Within this study we will focus on the canonical pathway,
which controls nuclear translocation of the p50/RelA (NF-
κB1/RelA) heterodimer. Following activation of a cell mem-
brane receptor and propagation of intracellular signalling, the
canonical pathway ultimately results in activation of the IκB
Kinase (IKK) complex. The IKK trimer within the canonical
pathway consists of two kinase subunits IKKα and IKKβ,
along with the regulatory subunit IKKγ (NF-κB Essential
Modulator (NEMO) [12], [13]). Activation of IKK induces
phosphorylation-dependent degradation of IκB and release of
NF-κB. As such, IKK is a key component of the signalling
pathway, whose dynamics have a significant effect on the
downstream activation of NF-κB and resultant gene expression
for immune response.
We have utilised the concept of communicating X-Machines
[14], [15] to develop an agent-based model of the IL-1 stimu-
lated NF-κB signalling pathway. Specific focus has been made
in this study to IKK dynamics and its affect on downstream ac-
tivation of NF-κB. We have performed three simulation-based
experiments relating to: variations in the binding probability
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of IKK to the inhibited NF-κB-IκBα complex; the temporal
rebinding delay of IKK to additional inhibited complexes
following the relase of free NF-κB from a prior inhibited
complex; and variations in the numbers of IKK molecules
within the system. Our agent-based model suggests that the
pathway is sensitive to variations in the binding probability of
IKK to the inhibited NF-κB-IκBα complex, and variations in
the temporal rebinding delay of IKK.
The paper has the following structure: in Section II we
provide a brief overview of the NF-κB signalling pathway
in the form of a conceptual model; Section III provides a
high-level technical design for our computational model based
on the concept of Communicating X-Machines; Section IV
introduces our agent-based model using the FLAME simu-
lation framework; Section V presents our simulation-based
experimental results; and finally, Section VI presents our
conclusions.
II. CONCEPTUAL MODEL
We have previous discussed the need for new computational
models of the signalling pathway [16]. Furthermore, we have
recently developed a conceptual model of the IL-1 stimulated
NF-κB signalling pathway using the Unified Modelling Lan-
guage and a number of statistical techniques [17]. As such,
we will provide the biological context to our study through a
brief discussion in this section, and direct the reader to our
previous work for the detailed conceptual model.
Briefly, the signalling network commences with an ex-
tracellular signalling molecule binding to a cell membrane
receptor (a member of the TLR/IL-1 receptor superfamily).
The receptor then dimerises, and co-receptors such as CD14
[18], MD2 [19] (in the case of TLR4, [20]) and/or TILRR
[21], [22] (in the case of IL-1RI/IL-1AcP) help facilitate and
amplify the receptor response, and in situations where the
MyD88 adaptor protein binds, it mediates association of the
receptor complex with IRAK protein kinase [23], which in
turn activates TRAF6 [24] for propagation of the signal. Once
activated, TRAF6 continues signal transduction through activa-
tion of TAK1, which subsequently activates the IKK complex
[25]. The activated IKK complex chemcially modifies NF-κB
inhibitors, such as IκBα, which facilitates its dissociation from
the NF-κB molecule within the complex [26]. The released
IκBα undergoes a second modification (ubiquitination) [27],
which then targets IκBα for rapid degradation within the cell.
Conversely, the released NF-κB is able to translocate from the
cytosol to the nucleus, where it is subsequently activated and
binds cognate transcriptional sites to induce gene activation.
Figure 1 presents an overview of the signalling network.
III. HIGH-LEVEL TECHNICAL DESIGN
Signalling pathway dynamics are stochastic and it has been
found that at a population level, the individual cells follow
a negative binomial distribution with respect to degradation
dynamics of the inhibitor IκBα and resultant activation of free
NF-κB, which are the key dynamics that we are interested
[17]. As such, we believe that the modelling paradigm of
Fig. 1. Simplified cartoon diagram depicting the high-level interactions
between the cell membrane receptors, co-receptors and adaptor proteins, and
protein kinases within the NF-κB canonical signalling pathway. Reproduced
from [17] under a Creative Commons Attribution License (CC BY 4.0).
agent-based modelling provides the most appropriate means to
simulate the variability seen at the population level of single
cells. From a technical perspective, all system components are
generalisable as cell components, and will contain a standard
set of attributes (e.g. 3D coordinates, along with movement
parameters and functions).
There are four key categories of components, which relate
to: an organelle, which for our purposes has been abstracted
away to consist of only the cytoplasm and the nucleus; a re-
ceptor, which can be either the IL-1R cell membrane receptor
or a nuclear transporter (importing or exporting); a membrane,
which has been abstracted away to only incorporate the cel-
lular membrane or the nuclear membrane; and biomolecules,
which reflect the main signalling proteins: MyD88 adaptor
protein, transcription factor NF-κB, inhibitor IκBα, enzyme
IKK, and protein kinases IRAK and TRAF6. In addition,
our computational model of the single cell environment will
require a number of compartments to approximate to the
internal structure of a cell. Regarding the containment of
agents, the cell membrane, nuclear membrane, cytoplasm and
nucleus, effectively operate as the biological environment for
simulations, as they provide the necessary cell structure within
which the various biomolecules (e.g. NF-κB, IκBα and IKK
agents) interact. The cell membrane receptors (IL-1R) are
confined to the cell membrane, and the nuclear transporters to
the nuclear membrane. The IKK and NF-κB-IκBα complex
agents are confined to the cytoplasm, however free NF-κB
and IκBα agents are able to move between the cytoplasm
and nucleus, mediated by the nuclear transporters. Relative to
the transcription factor, the inhibitor IκBα is in excess within
the biological system [28], [29]. The current study focuses
specifically on the activation of the NF-κB-IκBα complex,
which is present at a 1:1 ratio [30]. Figure 2 represents one
Fig. 2. UML state machine diagram depicting the state changes of different agent types, and the relationships between these different agent types.
view of our abstracted technical design using a set of linked
UML state machine diagrams.
There are a number of different agent-based modelling
frameworks and development environments in use [31], which
represent agents through a number of different computational
techniques. The one thing these techniques have in common,
however, is that they portray the agent as having a defined
state at any particular moment in time. Representations of the
agent may therefore be viewed as a state machine, where the
current input in combination with all past inputs (previous
states) determines the output (next state) of the agent.
A communicating X-Machine model is a formalised math-
ematical model that can be used to compute the functional
behaviour of smaller components (i.e. individual agents),
whose dynamics may be aggregated to generate the emergent
behaviour within the entire system. The communicating X-
Machine is based upon a simple set of rules that describe
what the agent must/could do under different circumstances,
and how the various agents may communicate with each other.
They utilise a 10-tuple formal notation, with CXi representing




- Σ and Γ are the input and output alphabets respec-
tively.
- Q is the finite set of states.
- M is the (possibly) infinite set called memory.
- Φ, the type of the X-Machine X, is a set of partial
functions ϕ that map an input and a memory state to
an output and a possibly different memory state, ϕ :
Σ x M → Γ x M.
- F is the next state partial function, F : Q x Φ → Q,
which given a state and a function from the type Φ
determines the next state. F is often described as a
state transition diagram.
- q0 and m0 are the initial state and initial memory
respectively.
- IΦi is the communication interface for the input
messages.
- OΦi is the communication interface for the output
messages.
Holcombe [33] defines an X-Machine as a system that has
an internal computational state and an internal memory, which
can transition to another state dependent on environmental
input and their current internal state. The communicating X-
Machine is therefore able to encapsulate both the dynamic and
functional behaviour of an agent, as well as the underlying
data that it is modelled on, in a single process specification
[14]. Communication between individual X-Machines occurs
through a ‘communication matrix’, which is essentially a
message board that facilitates the reading and writing of in-
formation between every X-Machine, allowing communication
and interaction between the machines. Individual agents start
with an initial computational state, and upon receiving an
external input (e.g. communication from another agent), they
update this state, based on the rule regarding their current state
and the particular external input received [15], [34]. Following
this, it will change internal and/or memory state, potentially
generate a message for communication, or continue its current
behaviour.
IV. COMPUTATIONAL MODEL
We have used the Flexible Large-scale Agent-based Mod-
elling Environment (FLAME) [35], [36] to develop our com-
putational model. FLAME itself is not a true modelling
platform in the purest sense, instead it requires the modeller to
use templates to define the agent-based model, and then parse
and compile these using the packaged parser and associated
APIs. Due to FLAME utilising the concept of communicating
X-Machines, the agents are modelled using XML templates
to define the attributes and internal states of the agent, and C
code is used to define the rule-based functions of the agent be-
haviour. Through the use of messages to communicate changes
within the system’s environment, and transition functions,
which define the rule-based logic of the computational model,
the agents are able to transition to a new state and update their
internal memory as the simulation progresses. Once a model is
specified using the XML and C templates, the FLAME mod-
elling framework is able to automatically generate simulation
code (via the xparser programme) that allows communication
between X-Machines (agents) through its own communication
library, called Message Board. Through interfacing to the
Message Passing Interface (MPI) communication framework,
the simulation code is also fully compliant with parallel
hardware platforms, enabling efficient communication between
the individual agents, and ensuring that concurrently executing
agents remain in sync with each other [37].
Our agent-based model was developed in accordance with
the conceptual model and calibrated to wet-lab biological
data. As discussed by Kirschner [38], there are several ap-
proaches for estimating the parameter values of computational
models during the calibration process: 1) direct experimental
determination of a parameter; 2) simultaneous estimation of
several parameters at once by fitting experimental data to a
model; and 3) estimation of a parameter based on known
values for a similar system. The calibration process that we
utilised to align the behaviour of our computational model
with that of the underlying biological system used a mixture
of the three approaches discussed by Kirschner for parameter
value estimation. Environmental parameter values such as
cell and nuclear diameter have been approximated from the
literature. A number of parameter values regarding agent
interactions were arbitrarily set, such as the interaction radius
within which agents need to enter before they are eligible
for probabilistic binding, and the delay applied to nuclear
receptors following translocation of an agent before they may
translocate another agent. Additionally, the parameters that we
believe are fundamental to the emergent behaviour of our
computational model were estimated through a process of
varying parameter values during multiple simulation runs, until
simulation dynamics approximated (through qualitative curve-
fitting) to those of the wet-lab data of Carlotti et al [39] and
Yang et al [40]. Calibration through varying parameter values,
was therefore iterative, with each parameter being the focus of
investigation, and required consultation between the modeller
and domain expert until a parameter space was found that
Fig. 3. Calibrated dynamics using the median average distribution of 175
replicate simulation runs using different PRNG seed values.
yielded qualitative alignment to the underlying biological data
on which the computational model was designed (see figure 3
for calibrated dynamics). Finally, aleatory uncertainty analysis
[41] indicated that a minimum of 175 simulation replicates
using different pseudo-random number generator (PRNG) seed
values was required to provide simulation results with stable
median average dynamics - this was necessary to ensure we
are able to infer cause and effect relationships within our
simulation-based experimentation, and not be influenced by
type 1 errors (false positives) due to the stochasticity within
simulation runs using PRNG (using C Library stdlib.h).
V. SIMULATION-BASED EXPERIMENTATION
Computational models are simplified versions of reality,
often with no direct one-to-one translation between the com-
putational model and the real-world domain. The calibration
process therefore compensates for this mapping, to ensure
that simulation dynamics approximate to the dynamics of the
real-world domain. The relationship between the abstracted
computational model and the biological system (in our case the
IL-1 stimulated NF-κB signalling pathway) is critical for using
the results of simulation-based experimentation in a predictive
capacity to generate novel hypotheses for testing within the
wet-lab. As such, epistemic uncertainty analysis focuses on the
lack of knowledge regarding certain parameter values [41], the
abstracted nature of computational models, and the effects of
varying the absolute parameter values that have been defined
through the calibration process [42].
The IL-1 stimulated dynamics within our computational
model relate to the IKK-mediated release of NF-κB from the
NF-κB-IκBα complex, the associated degradation of IκBα,
and the translocation of the free NF-κB (that had been released
via IKK) in to the nucleus. As such, we believe that IKK is a
key component for modulating the signalling pathway, and
will be the focus of our simulation-based experimentation.
The three experiments discussed in this paper relate to the
robustness of the system regarding IKK dynamics. The first
two experiments focus on the epistemic uncertainty regarding
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Fig. 4. Two-dimensional heatmap of the IKK binding probability parameter
versus the Nuclear Import probability parameter under IL-1 stimulation. A
shows the variation in the total number of NF-κB agents within the cytoplasm.
B shows the variation in the total number of NF-κB agents within the nucleus.
The heatmap key represents distance away from the calibration range, e.g. dark
blue areas represent the parameter values within the calibration range, and red
signifies parameter values considerably outside of the calibration range.
the calibration values for the probability of an IKK agent
binding to an inhibited NF-κB-IκBα complex, along with the
time delay of IKK before it is allowed to bind to another
inhibited NF-κB-IκBα complex. The final experiment relates
to the effects of varying the number of IKK agents on the
system.
A. IKK Binding Probability
An enzyme needs to be within a close enough proximity
to substrate molecule(s) in order to catalyze a reaction and
form the relevant product(s). Furthermore, even though the
complementary molecules (enzyme and substrate(s)) may be
within an appropriate distance (interaction zone), the actual
biochemical reaction is not a certainty, and as such conforms to
a probabilistic reaction. Our computational model reflects this
stochastic nature through the use of an IKK binding probability
parameter.
During calibration of the computational model, we noted
complex dynamics for cytoplasmic and nuclear NF-κB in both
free and inhibited states. We further noted that total NF-κB
agents within the cytoplasm and nucleus showed a degree of
stability however, which reflected the wet-lab findings in [43].
We conjecture that this may represent non-linear dynamics
of the nuclear import (under IL-1 stimulation) parameter,
that may be co-dependent on IKK mediated dissociation of
free NF-κB through IKK-mediated catalysis, which in our
computational model is represented using the IKK binding
probability parameter.
We tested the effects that the IKK binding probability
parameter has on system dynamics through performing a
two-at-a-time analysis between the IKK binding probability
parameter and the nuclear import probability parameter under
IL-1 stimulation. The resulting 2D heatmaps (figure 4) suggest
that desired total NF-κB agent numbers within the nucleus
and cytoplasm are generated when nuclear import (under IL-1
stimulation) parameter value is between 0.75 to 1.0, and when
the IKK binding parameter value is between 0.75 to 1.0, which




Fig. 5. The IKK rebind delay parameter shows a degree of robustness to
variations in its absolute value. A shows the variation in the number of NF-κB
agents within the cytoplasm. B shows the variation in the number of NF-κB
agents within the nucleus. C shows the variation in the number of NF-κB-
IκBα agents within the cytoplasm. D shows the variation in the number of
NF-κB-IκBα agents within the nucleus. It can be seen that system dynamics
are robust for IKK rebind delay parameter values between 4 to 18.
B. IKK Rebind Delay
Following an enzyme catalyzed reaction in biological sys-
tems, the enzyme molecule will need to release the product
molecule from the reaction and may also need a period of
time to re-establish its 3-dimensional physical structure (con-
formational change) in order to accept another set of substrate
molecules for a subsequent round of catalysis. The IKK rebind
delay parameter within our computational model reflects this
time delay (simulation run iterations), and introduces a lag
period to individual IKK agents following release of free
NF-κB (product) from one round of catalysis and interaction
with an inhibited NF-κB-IκBα complex (substrate) in the next
round of catalysis.
We tested the effects that the IKK rebind delay has on
system dynamics through varying the time delay (number of
simulation run iterations) that IKK agents incur before they
are able to bind with another inhibited NF-κB-IκBα complex
and promote the release of free NF-κB. The system showed a
remarkable degree of robustness during. Figure 5 higlights that
computational model dynamics are sensitive when simulations
use IKK rebind delays between 1 to 4 time-steps, but very
stable with values between 4 to 18 time-steps.
C. IKK Numbers
Following IL-1 stimulation and activation of receptor com-
plex components, the signal transduction reaches the NF-
κB-IκBα signalling module [44], with the key step being
the IKK-mediated dissociation (and resultant degradation) of
IκBα [12]. This causes release of NF-κB, and facilitates its
translocation into the nucleus and subsequent activation, to
initiate transcription of genes for the inflammatory response.
Although computing power continues to increase, the
prospect of us developing a computational model using bi-
ological levels of agents is still an intractable problem. As
such, simulation dynamics have been calibrated using 501
IκBα and 502 NF-κB (both in various states of free, bound,
cytoplasmic and nuclear), along with 500 agents each of IL-
1R cell membrane receptor, MyD88, IRAK, TRAF6, and 50
IKK agents. Although these numbers are somewhat arbitrary,
calibration of the computational model compensated for this
design decision. In addition, as the IKK enzyme is able to
catalyze numerous reactions, the system needs far fewer IKK
agents than its substrate (the inhibited NF-κB-IκBα complex),
due to the amplificatory nature of enzymes within signalling
pathways.
This provides an opportunity for us to investigate the effects
of varying IKK numbers (akin to varying concentration in
wet-lab experiments), and whether the system is robust to
such perturbations. As there is an amplification step, i.e. one
IKK agent can facilitate dissociation of many NF-κB-IκBα
complexes over the lifetime of a simulation, it is expected that
an increase in IKK numbers would increase the rate at which
active NF-κB accumulates in the nucleus. This experiment
therefore allows us to qualify the change in system dynamics
along with the extent of robustness (or indeed fragility) within
the system that is directly attributable to IKK number.
Experimentation into the effects of varying IKK numbers,
is conducted through perturbation of the total number of
IKK agents. By default, there were 50 IKK agents within
the calibrated simulation platform. To test the effects, we
ran six sets of simulation-based experiments using a tenth,
a fifth, a half, 2x, 5x, and 10x default numbers (i.e. 5, 10,
25, 100, 250 and 500 IKK agents, respectively). For each
set of 175 simulation replicates, the median distributions
of cytoplasmic NF-κB, nuclear NF-κB, cytoplasmic NF-κB-
IκBα, nuclear NF-κB-IκBα, cytoplasmic IκBα and nuclear
IκBα over the lifetime of the simulation runs are interpolated.
These distributions are contrasted with the baseline behaviour
that results from simulations using the default number of
IKK agents. Kolmogorov Smirnov (KS) tests [45] are then
performed to understand whether there are any statistically
significant differences from baseline behaviour (requiring p-
values below 0.05), and the Vargha and Delaney A-Tests [46]
are also performed to understand the effect magnitude of these
differences, assuming ‘large’ differences of < 0.29 and > 0.71
to be scientifically significant.
Results indicate that the system is sensitive to perturba-
tions involving the total number of IKK agents, which in
effect alters the ratio of IKK to inhibited complex NF-κB-
IκBα, and the ratio of IKK to free NF-κB and IκBα within
the system. An increase in IKK numbers results in both
a decrease in cytoplasmic NF-κB-IκBα numbers, but also
an increase in the rate of dissociation of the NF-κB-IκBα
complexes. The effects on cytoplasmic NF-κB numbers are
not as straightforward to interpret, as there appears to be a
non-linear temporal component at play, whereby an increase
in IKK numbers results in an initial increase in cytoplasmic
Fig. 6. The non-linear cytoplasmic NF-κB dynamics for the six sets of
experiments into IKK concentration, which have been compared against
baseline IL-1 stimulated dynamics.
NF-κB numbers upto approximately 15min, after which there
is a sharp decrease, resulting in a negative relationship between
the number of IKK agents and the number of cytoplasmic NF-
κB agents at the end of simulation runs (see figure 6). KS
tests indicate that all perturbations to IKK numbers provide
statistically significant differences (with respect to baseline
dynamics) across all agent states, apart from nuclear IκBα, and
the cytoplasmic and nuclear NF-κB-IκBα agent states when
50% of default IKK numbers are used (i.e. 25 IKK agents).
Furthermore, the corresponding effect magnitude using the A-
Test, indicate scientifically significant differences exist for:
cytoplasmic NF-κB-IκBα in all perturbations, nuclear NF-κB
and active NF-κB for perturbations that used 10%, 20%, 500%
and 1,000% IKK (with respect to default); and cytoplasmic
IκBα for perturbations that used 10% and 20% of IKK (with
respect to default).
VI. CONCLUSION
Computational models provide not only a means to rigor-
ously think about and describe complex dynamical systems,
but also provide an opportunity for us to extend our knowledge
of system dynamics through performing novel simulation-
based experimentation, and extrapolating these results back
to the real-world system. Our agent-based model contains
additional granularity at the cell membrane receptor complex
with respect to existing models, through explicit modelling of
the IL-1R, MyD88, TRAF, and IRAK components. It has been
developed using the concept of communicating X-Machines,
which should ensure the model can be run across multiple
computing architectures (e.g. laptop, desktop, cluster and grid),
and calibrated against wet-lab data of Carlotti et al [39]
and Yang et al [40], to ensure that the model can be used
for predictive purposes against the IL-1 stimulated NF-κB
signalling pathway, at the single-cell level. As such, we believe
that our computational model provides a suitable platform to
perform additional simulation-based experimentation around
the IL-1 stimulated NF-κB signalling pathway.
Following the discovery of [12], that the signal-induced
activation of NF-κB requires phosphorylation of the inhibitory
IκBα molecule (within the inhibited NF-κB-IκBα complex),
and its subsequent proteolytic degradation, we now know that
the initial phosphorylation to dissociate the IκBα molecule and
release free NF-κB is performed by IKK. This has provided us
with an opportunity to investigate three key factors involved
in IKK dynamics within our computational model, namely:
the probabilistic binding of IKK to its substrate (the inhibited
NF-κB-IκBα complex); the temporal delay in IKK binding
to a new NF-κB-IκBα complex, for a subsequent round of
catalysis; and the effects of varying IKK number.
Simulation-based experimental results indicate that the sys-
tem is remarkably robust to perturbations in IKK binding
probability, which we conjecture could be due to both the
amplificatory nature of enzymatic reactions, and the continu-
ous movement of agents within the cytosol, thus facilitating
enzymatic reactions through individual substrate and enzyme
moving into a suitable interaction zone, which would provide
multiple opportunities for an enzymatic reaction to occur dur-
ing the lifetime of a simulation. The second set of simulation-
based experimatal results also indicated the system is on the
whole robust to perturbations in the temproal delay for IKK
agents before they may catalyse the next round of reactions,
but is sensitive to perturbations over a small region of 1-4 time-
steps (simulation iterations). We conjecture that this sensitivity
may be due to the probabilistic nature of catalysis, and that a
short delay is required to allow the substrate to move out of
the interaction zone following a probabilistic interaction that
did not result in a catlysed reaction.
The third set of simulation-based experimental results in-
dicate that the system is stable to perturbations in IKK
numbers within a small range either side of the calibrated
value (i.e. between 50% and 200%), but sensitive to more
extreme perturbations (i.e. 10%, 20%, 500%, and 1,000%).
Using these higher IKK numbers (i.e. 500% and 1,000% of
the calibrated value), results also indicate that an increase in
the number of IKK agents, leads to: a decrease in cytoplasmic
IκBα; a decrease in both cytoplasmic and nuclear NF-κB-
IκBα complex, along with an associated increase in the disso-
ciation of the complexes; and no significant change to either
nuclear NF-κB-IκBα complexes or nuclear IκBα, although
we suspect that this is due to the small absolute numbers
that are associated with the calibrated simulation platform.
Additionally, a small change in cytoplasmic IκBα was found
when perturbing the system with low IKK numbers (i.e. 10%
and 20% of the default value). KS-Tests and subsequent A-
Tests provide additional support to these interpretations, by
indicating scientifically significant differences for cytoplas-
mic NF-κB-IκBα complexes under all perturbations to IKK
number, and nuclear (both free and active) NF-κB under all
perturbations to IKK number, apart from 50% and 200% of
the default value for IKK numbers. Unfortunately, the effects
on cytoplasmic NF-κB are not as straightforward to interpret,
as non-linear temporal dynamics emerge. We believe that
these non-linear dynamics of cytoplasmic NF-κB are due to
the rapid increase in dissociation of NF-κB-IκBα complexes
to yield free NF-κB, and then subsequent translocation to
the nucleus whereby these IKK-mediated free NF-κB agents
become activated and remain in the nuclear compartment. As
such, we believe that an increase in IKK numbers generates
an initial increase in cytoplasmic NF-κB, which then slowly
reduces over time through translocation to the nucleus. Once
in the nucleus, the NF-κB becomes activated and thus remains
there until the end of the simulation, due to the abstractions
that we have taken as part of our platform model - we have
developed a minimal model that focuses on the signalling
pathway upto and including NF-κB activation.
In conclusion, this paper has described a principled ap-
proach to design, development and calibration of an agent-
based model of the IL-1 stimulated NF-κB signalling pathway;
along with subsequent simulation-based experimentation to
investigate various aspects of the pathway at the component-
level, to provide insight to the nature of the underlying
mechanisms and dynamics. Although we are confident that
the computational model has adhered to good software engi-
neering practices, the modelling activities were not the end
goal itself, but were instead incremental activities for the
development of a tool to increase our understanding of the
signalling pathway. As such, it is hoped that future researchers
will use our agent-based model to perform additional, novel,
simulation-based experiments. We believe that an increased
understanding of the pathway under normal physiology and
disease, will elucidate the underlying causes of inflammatory
diseases, and lead to new treatment strategies.
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